...
首页> 外文期刊>Viral immunology >Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype
【24h】

Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype

机译:对诺如病毒GII-4病毒样颗粒的预先存在的免疫力不会削弱对诺如病毒GII-12基因型的从头免疫反应

获取原文
获取原文并翻译 | 示例
           

摘要

Noroviruses (NoVs) are one of the leading causes of acute nonbacterial gastroenteritis in humans of all ages. In the 1990s, NoV genotype GII-4 became responsible for the majority of NoV sporadic gastroenteritis cases and outbreaks worldwide. Vaccine development against NoV GII-4 is underway. At the same time, there is concern of new emerging NoV genotypes, such as GII-12, which has been recently associated with increasing numbers of NoV outbreaks worldwide. The specific question is whether type-specific pre-existing immunity to NoV GII-4 might impair cognate immune response induced by new viral infections or vaccines. Using GII-4 and GII-12 virus-like particles, we tested the impact of the immunity generated against NoV GII-4 on de novo antibody responses to GII-12 in mice. We found that pre-existing immunity to NoV GII-4 did not impair de novo immune response to the novel antigen, therefore suggesting lack of original antigenic sin (OAS).
机译:诺如病毒(NoVs)是所有年龄段的人类急性非细菌性胃肠炎的主要原因之一。在1990年代,NoV基因型GII-4成为了全球大部分NoV散发性肠胃炎病例和暴发的原因。针对NoV GII-4的疫苗开发正在进行中。同时,人们担心新出现的NoV基因型,例如GII-12,最近与全球NoV暴发数量增加有关。一个具体的问题是对NoV GII-4的特定类型的预先存在的免疫是否会削弱新病毒感染或疫苗诱导的同类免疫反应。使用GII-4和GII-12病毒样颗粒,我们测试了针对NoV GII-4产生的免疫力对小鼠对GII-12的从头抗体应答的影响。我们发现预先存在的对NoV GII-4的免疫不会削弱对新抗原的从头免疫反应,因此表明缺乏原始的抗原性罪过(OAS)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号